AstraZeneca vaccine: a volunteer from India sues for adverse reactions to laboratories

A volunteer from India who conducted the trials of the jointly produced vaccine by the laboratory AstraZeneca and the Oxford University against COVID-19, he sued for more than half a million dollars the Indian person in charge of carrying out the tests.

The coordination was in charge of the Serum Institute of India, an institution demanded by the volunteer, according to the Indian media, for fifty million rupees, around 676 thousand dollars.

Along with the amount of money, the volunteer also requested that the vaccine trials be stopped immediately on the rest of the 1,600 people in which it is applied.

What happened to the Indian volunteer

The wife of the AstraZeneca vaccine volunteer, whose identity has not been revealed so far, said the man received the first of two doses of the vaccine on October 1.

Everything started well since after the first application, they carried out a test eleven days later and where antibodies were detected in the volunteer’s body. This was the first confirmation that the man was given the vaccine and not a placebo.

The monitoring continued to record how the tests on how the immune system would react developed.

The plaintiff’s wife recounted that one moment her husband began to experience severe headaches and then the nausea and vomiting began. The next adverse reaction was that the man seemed lost and began to ignore his entire family environment.

According to reports in the Indian press, the patient was admitted to the Sri Ramachandra Hospital and Medical College, where after being discharged from the hospital, where he was admitted between October 11 and 26, it was indicated that he was “in an altered state of mind “and” disoriented.

The volunteer’s condition continued to get worse and worse. According to reports in the Indian press, he had to be transferred and urgently admitted to Sri Ramachandra Hospital and Medical College.

In the medical institution they received him with an “altered mental state and very disoriented in time and place.” The volunteer was hospitalized between October 11 and 26, during that period they managed to stabilize him.

The neurological disorders of the Indian volunteer

The patient’s wife said that after being discharged they performed a series of neurological tests that confirmed considerable brain dysfunction. “He is recovering slowly and is better than he was but he cannot work as before,” the volunteer’s wife told the Indian media.

The response of the laboratories

Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in the city of Pune, India, which was founded in 1966 by Cyrus Poonawalla.

Dr Ramakrishnan, principal investigator of the trial in India, was the person in charge of treating the patient who had brain damage. In communication with the main media in the Asian country, he said that the volunteer “is doing well now.”

Ramakrishnan added that the institutional ethics committee of the hospital where the patient was treated noted that the adverse reaction was not due to the vaccine. However, it is unknown, until now, what produced it.

TOPICS THAT APPEAR IN THIS NOTE